However, before we dismiss statin therapy in women, a few factors must be considered.Bangalore,S.Messerli,F.H.The American Journal of CardiologyBangalore S and Messerli FH. Statin therapy for second- ary prevention: is there a gender difference? Test for inter- action in meta-analysis ...
[14]Mansi IA, Chansard M, Lingvay I, Zhang S, Halm EA, Alvarez CA. Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study. JAMA Intern Med. 2021 Dec 1;181(12):1562-1574. [15]Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd...
High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review. J Cardiovasc Nurs. ... DW Schwertz,KO Badellino - 《Journal of Cardiovascular Nursing》 被引量: 0发表: 2008年 Design and baseline characteristics of the strok...
To explore the current use of secondary prevention antiplatelet and statin therapy among community residents with established coronary heart disease(CHD) and ischemic stroke(IS) in central China, and to identify its associated individual characteristics. his study was based on the data collected from ...
Methods Randomized trials or systematic reviews for secondary prevention of CHD with statin therapy published between January 1966 and December 2002 were identified through MEDLINE and the Cochrane Library. Studies were included if they randomly assigned adults with CHD to statin therapy or control, enro...
Supplementary Methods for Definition of Secondary Endpoints Table 1. Inclusion and Exclusion Criteria eTable 2. Changes in Statin Intensity in the Treat-to-Target Strategy Group eTable 3. Statin Intensity Between Groups eTable 4. Lipid-Lowering Therapy eTable 5. Cardiovascular Medications eTable...
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations: should we target patients with the most to gain? J Gen Inter Med ... JJ Ellis,SR Erickson,JG Stevenson,... - 《Value in Health》 被引量: 245发表: 2002年 Adherence to statin therapy and patients'...
PCV15 EFFECT OF STATIN THERAPY ON RISK OF CORONARY DISEASE IN PRIMARY AND SECONDARY PREVENTION TRIALS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALSPCV15 EFFECT OF STATIN THERAPY ON RISK OF CORONARY DISEASE IN PRIMARY AND SECONDARY PREVENTION TRIALS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS...
Given the substantial benefits of statin therapies in both primary and secondary prevention of cardiovascular disease, their long-term safety has become a concern. The potential harmful effects of statin therapy on muscle and liver have been known for some time, but new concerns have emerged ...
In 2016, the US Preventive Services Task Force (USPSTF) issued its first recommendations for statin therapy for the primary prevention of cardiovascular disease based on an evidence review that included 19 randomized clinical trials (RCTs).1 In this issue of JAMA, the USPSTF presents an update2...